None

Property fund Indiareit's CEO quits to start own venture-sources

MUMBAI, Sept 1 (Reuters) - The head of Indiareit Fund Advisors, an Indian real estate fund and unit of drugmaker Piramal Healthcare, has decided to step down to explore setting up his own fund, source...

RPT-Property fund Indiareit's CEO quits to start own venture-sources

MUMBAI, Sept 1 (Reuters) - The head of Indiareit Fund Advisors, an Indian real estate fund and unit of drugmaker Piramal Healthcare, has decided to step down to explore setting up his own fund, source...

Piramal Imaging Welcomes Ana M. Catafau, M.D., Ph.D., as VP, Clinical Research and Development, Neurosciences

BERLIN, BOSTON and MUMBAI, India, May 7, 2013 /PRNewswire/ -- Piramal Imaging SA, a division of Piramal Enterprises, today announced Ana M. Catafau, M.D., Ph.D., has joined the company as vice preside...

Decision Resources Group Acquires Abacus International

Decision Resources Group, one of the world’s leading research and advisory firms focusing on healthcare insights and analysis, announced today that it acquired Abacus Internatio...

Fujifilm Diosynth Biotechnologies Announces Strategic Alliance with Piramal Healthcare for ...

Billingham, UK / Morrisville, NC, USA, October 24, 2012 / B3C newswire / – Fujifilm Diosynth Biotechnologies has announced it has entered into a strategic alliance with Pirama...

Indian Pharma MNC Piramal Investing in German Molecular Imaging Technology

BERLIN, August 30, 2012 /PRNewswire/ -- Innovative medical research in Germany In April 2012, Indian MNC Piramal took over Bayer HealthCare's molecular-imaging pipeline and has since then been...

Piramal Imaging Announces the Acceptance for Review of [18F] florbetaben by the FDA and EMA for the Visual Detection of beta-amyloid in Alzheimer's Disease

BOSTON and MUMBAI, India, March 21, 2013 /PRNewswire/ -- Piramal Imaging SA, a division of Piramal Enterprises, today announced that the Food and Drug Administration (FDA) and the European Medicines...

None